aminoimidazole carboxamide has been researched along with Experimental Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedard, N; Di Marco, S; Ford, RJ; Gallouzi, IE; Griss, T; Hall, DT; Jones, RG; Ma, JF; Mubaid, S; Omer, A; Pause, A; Sadek, J; Sanchez, BJ; Steinberg, GR; Tremblay, AMK; Wing, SS | 1 |
| Carson, JA; Gao, S; Puppa, MJ; Sato, S; Welle, SL; White, JP | 1 |
| LAW, LW; MANDEL, HG | 1 |
| Giri, S; Rattan, R; Singh, AK; Singh, I | 1 |
| Candiani, GP; Luini, W; Mantovani, A; Spreafico, F | 1 |
| Boland, MP; Friedlos, F; Knox, RJ; Kotsaki-Kovatsi, VP; Marchbank, T; Roberts, JJ | 1 |
6 other study(ies) available for aminoimidazole carboxamide and Experimental Neoplasms
| Article | Year |
|---|---|
The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Animals; Cachexia; Cell Line; Enzyme Activation; Inflammation; Interferon-gamma; Male; Metformin; Mice, Inbred BALB C; Mitochondria; Muscle, Skeletal; Neoplasms, Experimental; Nitric Oxide Synthase Type II; Protein Kinases; Ribonucleotides; Shock, Septic; Tumor Necrosis Factor-alpha | 2018 |
Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Cachexia; Interleukin-6; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Multiprotein Complexes; Muscle Fibers, Skeletal; Muscle, Skeletal; Neoplasms, Experimental; Phosphorylation; Physical Conditioning, Animal; Proteins; Pyrazoles; Pyrimidines; Real-Time Polymerase Chain Reaction; Recombinant Proteins; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; TOR Serine-Threonine Kinases | 2013 |
The effect of 4-amino-5-imidazolecarboxamide on the carcinostatic action of 8-azaguanine.
Topics: Aminoimidazole Carboxamide; Animals; Azaguanine; Guanine; Imidazoles; Neoplasms, Experimental | 1954 |
5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Humans; In Vitro Techniques; Male; Mice; Mice, Knockout; Models, Biological; Multienzyme Complexes; Neoplasms, Experimental; Oligodeoxyribonucleotides, Antisense; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Ribonucleotides; S Phase; Transfection | 2005 |
Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice.
Topics: Aminoimidazole Carboxamide; Animals; Azathioprine; Cyclophosphamide; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Doxorubicin; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mycobacterium bovis; Neoplasms, Experimental | 1980 |
Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Aziridines; Caffeine; Cross-Linking Reagents; Dicumarol; DNA; Drug Synergism; NAD(P)H Dehydrogenase (Quinone); Neoplasms, Experimental; Quinone Reductases; Rats; Tumor Cells, Cultured; Vitamin K | 1989 |